Patricia Henry
Gastroenterology · Urbana, ILNPI 1629308663
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Pinnacle Biologics, Inc at 51.4% of the total. Reporting peaked in 2022 at $2,235 and has fallen 81.0% since, to $425 in 2025.
Across 45 payments — averaging $84.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle Biologics, Inc$2K
- AbbVie$639
- Conmed Corporation$306
- Medtronic$247
- Boston Scientific$182
- Phathom Pharmaceuticals, Inc.$116
- plus $354 from 9 others
Across 174 payments — averaging $2511.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$301K
- Regeneron$84K
- AbbVie$50K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
What the payments were for
- Speaking & faculty fees$1,00026%
- Travel & lodging$66718%
- Food & beverage$2,12356%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Photofrin$1,772
- CONMED BILIARY$306
- EndoFlip$146
- GENERAL - THERAPIES$144
- CONMED GENERATORS$141
- Creon$122
- Skyrizi$118
- VOQUEZNA$116
How this compares
$3,790 in reported general payments places this provider in the 70th percentile of 787 gastroenterology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alosetron Hcl | 13 | $8,814 |
| Omeprazole | 37 | $885 |
| Pantoprazole Sodium | 23 | $303 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Urbana
- David RubinChicago$1.5M
- Stephen HanauerChicago$1.4M
- Steven FlammChicago$1.3M
- Amar NaikDes Plaines$1.2M
- Darren BrennerChicago$1.1M
- Jonathan RosenbergGurnee$1M
- Daksesh PatelEvanston$745K
- Russell CohenChicago$690K
- Parambir DulaiChicago$668K
- Christopher ChapmanChicago$645K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.